241 related articles for article (PubMed ID: 26620313)
1. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
[TBL] [Abstract][Full Text] [Related]
2. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
3. Long-term stability of influenza vaccine in a dissolving microneedle patch.
Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
[TBL] [Abstract][Full Text] [Related]
4. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
[TBL] [Abstract][Full Text] [Related]
5. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
Nakatsukasa A; Kuruma K; Okamatsu M; Hiono T; Suzuki M; Matsuno K; Kida H; Oyamada T; Sakoda Y
Vaccine; 2017 May; 35(21):2855-2861. PubMed ID: 28431812
[TBL] [Abstract][Full Text] [Related]
6. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
[TBL] [Abstract][Full Text] [Related]
7. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
[TBL] [Abstract][Full Text] [Related]
8. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
[TBL] [Abstract][Full Text] [Related]
9. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
Ameri M; Ao Y; Lewis H
AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
[TBL] [Abstract][Full Text] [Related]
10. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825
[TBL] [Abstract][Full Text] [Related]
11. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
[TBL] [Abstract][Full Text] [Related]
12. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
Pharm Res; 2011 Jan; 28(1):135-44. PubMed ID: 20387097
[TBL] [Abstract][Full Text] [Related]
13. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
Kommareddy S; Baudner BC; Bonificio A; Gallorini S; Palladino G; Determan AS; Dohmeier DM; Kroells KD; Sternjohn JR; Singh M; Dormitzer PR; Hansen KJ; O'Hagan DT
Vaccine; 2013 Jul; 31(34):3435-41. PubMed ID: 23398932
[TBL] [Abstract][Full Text] [Related]
14. Development of a thermostable microneedle patch for influenza vaccination.
Mistilis MJ; Bommarius AS; Prausnitz MR
J Pharm Sci; 2015 Feb; 104(2):740-9. PubMed ID: 25448542
[TBL] [Abstract][Full Text] [Related]
15. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
[TBL] [Abstract][Full Text] [Related]
16. [Chitosan as an adjuvant for parenteral inactivated influenza vaccines].
Gendon IuZ; Markushin SG; Krivtsov GG; Akopova II
Vopr Virusol; 2008; 53(5):14-9. PubMed ID: 19069787
[TBL] [Abstract][Full Text] [Related]
17. [Increasing the immunogenicity of inactivated chitosan adjuvanted vaccine from A/California/7/09 (H1N1) strain and analyzing the antigenic specificity of this influenza virus strain].
Gendon IuZ; Markushin SG; Vasil'ev IuM; Akopova II; Krivtsov GG
Vopr Virusol; 2012; 57(1):28-33. PubMed ID: 22624470
[TBL] [Abstract][Full Text] [Related]
18. Dissolving polymer microneedle patches for influenza vaccination.
Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
[TBL] [Abstract][Full Text] [Related]
19. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
20. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.
Fernando GJ; Zhang J; Ng HI; Haigh OL; Yukiko SR; Kendall MA
J Control Release; 2016 Sep; 237():35-41. PubMed ID: 27381247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
